Clinical Trial Update: Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections [NA]

View source ↗

Summary

A completed clinical trial evaluated therapeutic plasma exchange as a strategy to alleviate hyperinflammation in severe COVID-19 infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Intensive Care Units, ARDS, Human | NA | Status: COMPLETED